Fairvalue-Calculator Fairvalue-Calculator
EN DE

Lumos Diagnostics Holdings (LDXHF) Fair Value & Analysis

Healthcare · US · Market cap $75.5M

Price$0.0800
Fair Value$0.0300
Upside-62.5%
Quality95/100
Evidence: Low Range $0.0200 – $0.0400

Fair value as of: Jun 24, 2026

Analysis

Lumos Diagnostics Holdings (LDXHF) currently trades at $0.0800, while our model-based Fair Value estimate is $0.0300 — implying the stock looks roughly 62.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company's products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -9% Boston Scientific Corporation (B1SX34) -83% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +19%

Frequently asked questions

Is Lumos Diagnostics Holdings (LDXHF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.0300 versus a price of $0.0800 — about −63% (overvalued). Model-based estimate, not financial advice.
What is the fair value of LDXHF?
Our 21-model fair value for Lumos Diagnostics Holdings is $0.0300 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.0800.
What is the quality score of LDXHF?
Lumos Diagnostics Holdings has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.